Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 Axis

Guosong Jiang(Union Hospital), Jiayan Gu(Wenzhou Medical University), Xingruo Zeng(New York University), Jingxia Li(New York University), Amy D. Wu(New York University), Dongyun Zhang(Army Medical University), Honglei Jin(Wenzhou Medical University), Chao Huang(Nanchang University), Jingxia Li(New York University), Liping Zhang(Wenzhou Medical University), Chuanshu Huang(Wenzhou Medical University), Haishan Huang(Mayo Clinic)
Cancer Prevention Research
April 14, 2016
Cited by 68


Related Papers